Erratum to: Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months
Titel:
Erratum to: Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months
Auteur:
Argüelles-Arias, F. Guerra Veloz, M. F. Perea Amarillo, R. Vilches-Arenas, A. Castro Laria, L. Maldonado Pérez, B. Chaaro, D. Benítez Roldán, A. Merino, V. Ramírez, G. Caunedo Álvarez, A. Romero Gómez, M.